Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended February 28, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission File Number: 001-35992
Oracle Corporation
(Exact name of registrant as specified in its charter)
Delaware
54-2185193
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2300 Oracle Way
Austin, Texas
78741
(Address of principal executive offices)
(Zip Code)
(737) 867-1000
(Registrant s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
3.125% senior notes due July 2025
ORCL
New York Stock Exchange
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The number of shares of registrant s common stock outstanding as of March 7, 2022 was: 2,668,157,000.
Table of Contents
ORACLE CORPORATION
FORM 10-Q QUARTERLY REPORT
TABLE OF CONTENTS
Page
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of February 28, 2022 and May 31, 2021
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended February 28, 2022 and 2021
Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended February 28, 2022 and 2021
Condensed Consolidated Statements of Stockholders (Deficit) Equity for the Three and Nine Months Ended February 28, 2022 and 2021
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended February 28, 2022 and 2021
Notes to Condensed Consolidated Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
26
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
45
Item 4.
Controls and Procedures
45
PART II.
OTHER INFORMATION
46
Item 1.
Legal Proceedings
46
Item 1A.
Risk Factors
46
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
46
Item 5.
Other Information
46
Item 6.
Exhibits
47
Signatures
48
Table of Contents
Cautionary Note on Forward-Looking Statements
For purposes of this Quarterly Report, the terms Oracle, we, us and our refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report on Form 10-Q contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21 of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These include, among other things, statements regarding:
the possible impact of the Russia-Ukraine situation on our business, including our belief that our profitability and the generation of positive cash flow from our operations will not be jeopardized by the current situation
our expectations regarding the impacts on our business as a result of the global COVID-19 pandemic
our expectation that we may acquire companies, products, services and technologies to further our corporate strategy as compelling opportunities become available
our expectations regarding the proposed acquisition of Cerner Corporation
our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and our license support offerings, and continued demand for our cloud license and on-premise license offerings
our expectation that substantially all of our customers will renew their license support contracts annually
our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business
our expectation that we will continue to make significant investments in research and development, and our belief that research and development efforts are essential to maintaining our competitive position
our expectation that our international operations will continue to provide a significant portion of our total revenues and expenses
our expectation that variable expenditures that were curtailed primarily in response to COVID-19 may normalize in future periods provided global economic and health conditions improve
our expectation that the proportion of our cloud services and license support revenues relative to our cloud license and on-premise license revenues, hardware revenues and services revenues will continue to increase
the sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, dividends, stock repurchases, debt repayments and other matters
our belief that we have adequately provided under U.S. generally accepted accounting principles for outcomes related to our tax audits and that the final outcome of our tax-related examinations, agreements or judicial proceedings will not have a material effect on our results of operations, our belief that our net deferred tax assets will likely be realized in the foreseeable future, and our expectations regarding the Build Back Better Act budget reconciliation bill
our belief that the outcome of certain legal proceedings and claims to which we are a party will not, individually or in the aggregate, result in losses that are materially in excess of amounts already recognized, if any
our expectation that certain litigation related charges will not recur
the possibility that certain legal proceedings to which we are a party could have a material impact on our financial position or results of operations
Table of Contents
the timing and amount of expenses we expect to incur
the cost savings we expect to realize pursuant to our Fiscal 2022 Oracle Restructuring Plan
declarations of future cash dividend payments and the timing and amount of future stock repurchases, including our expectation that the levels of our future stock repurchase activity may be modified in comparison to past periods in order to use available cash for other purposes
our expectations regarding the impact of recent accounting pronouncements on our consolidated financial statements
our expectation that, to the extent customers renew support contracts or cloud SaaS and IaaS contracts from companies that we have acquired prior to fiscal 2022, we will recognize revenues for the full contracts values over the respective renewal periods
our ability to predict revenues, particularly certain cloud license and on-premise license revenues and hardware revenues
the percentages of remaining performance obligations that we expect to recognize as revenues over respective future periods
as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements may be preceded by, followed by or include the words expects, anticipates, intends, plans, believes, seeks, strives, endeavors, estimates, will, should, is designed to and similar expressions. We claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about our business that could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Risk Factors included in documents we file from time to time with the U.S. Securities and Exchange Commission (the SEC), including our Annual Report on Form 10-K for our fiscal year ended May 31, 2021 and our other Quarterly Reports on Form 10-Q filed by us in our fiscal 2022, which runs from June 1, 2021 to May 31, 2022.
We have no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or risks, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. New information, future events or risks could cause the forward-looking events we discuss in this Quarterly Report not to occur. You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Quarterly Report.
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements (Unaudited)
ORACLE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
As of February 28, 2022 and May 31, 2021
(Unaudited)
(in millions, except per share data)
February 28,
2022
May 31,
2021
ASSETS
Current assets:
Cash and cash equivalents
22,682
30,098
Marketable securities
707
16,456
Trade receivables, net of allowances for doubtful accounts of $367 and $373 as of February 28, 2022 and May 31, 2021, respectively
4,588
5,409
Prepaid expenses and other current assets
3,698
3,604
Total current assets
31,675
55,567
Non-current assets:
Property, plant and equipment, net
8,609
7,049
Intangible assets, net
1,688
2,430
Goodwill, net
43,833
43,935
Deferred tax assets
13,109
13,636
Other non-current assets
9,730
8,490
Total non-current assets
76,969
75,540
Total assets
108,644
131,107
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Current liabilities:
Notes payable, current
6,248
8,250
Accounts payable
1,124
745
Accrued compensation and related benefits
1,626
2,017
Deferred revenues
7,871
8,775
Other current liabilities
3,964
4,377
Total current liabilities
20,833
24,164
Non-current liabilities:
Notes payable and other borrowings, non-current
72,165
75,995
Income taxes payable
12,168
12,345
Deferred tax liabilities
6,462
7,864
Other non-current liabilities
5,227
4,787
Total non-current liabilities
96,022
100,991
Commitments and contingencies
Oracle Corporation stockholders (deficit) equity:
Preferred stock, $0.01 par value authorized: 1.0 shares outstanding: none
Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares outstanding: 2,668 shares and 2,814 shares as of February 28, 2022 and May 31, 2021, respectively
26,129
26,533
Accumulated deficit
(33,147
(20,120
Accumulated other comprehensive loss
(1,678
(1,175
Total Oracle Corporation stockholders (deficit) equity
(8,696
5,238
Noncontrolling interests
485
714
Total stockholders (deficit) equity
(8,211
5,952
Total liabilities and stockholders (deficit) equity
108,644
131,107
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Nine Months Ended February 28, 2022 and 2021
(Unaudited)
Three Months Ended
February 28,
Nine Months Ended
February 28,
(in millions, except per share data)
2022
2021
2022
2021
Revenues:
Cloud services and license support
7,637
7,252
22,562
21,311
Cloud license and on-premise license
1,289
1,276
3,339
3,254
Hardware
798
820
2,328
2,478
Services
789
737
2,371
2,209
Total revenues
10,513
10,085
30,600
29,252
Operating expenses:
Cloud services and license support(1)
1,305
1,064
3,778
3,139
Hardware(1)
244
230
718
719
Services
669
621
1,984
1,875
Sales and marketing(1)
2,004
1,915
5,811
5,605
Research and development
1,816
1,621
5,254
4,812
General and administrative
335
330
953
949
Amortization of intangible assets
279
347
882
1,037
Acquisition related and other
20
13
4,707
107
Restructuring
19
66
89
337
Total operating expenses
6,691
6,207
24,176
18,580
Operating income
3,822
3,878
6,424
10,672
Interest expense
(667
(585
(2,051
(1,799
Non-operating expenses, net
(315
(17
(348
(30
Income before income taxes
2,840
3,276
4,025
8,843
(Provision for) benefit from income taxes
(521
1,745
(497
871
Net income
2,319
5,021
3,528
9,714
Earnings per share:
Basic
0.87
1.72
1.30
3.26
Diluted
0.84
1.68
1.26
3.19
Weighted average common shares outstanding:
Basic
2,670
2,913
2,711
2,977
Diluted
2,754
2,994
2,800
3,049
(1)
Exclusive of amortization of intangible assets, which is shown separately.
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the Three and Nine Months Ended February 28, 2022 and 2021
(Unaudited)
Three Months Ended
February 28,
Nine Months Ended
February 28,
(in millions)
2022
2021
2022
2021
Net income
2,319
5,021
3,528
9,714
Other comprehensive (loss) income, net of tax:
Net foreign currency translation (losses) gains
(63
132
(508
504
Net unrealized gains on defined benefit plans
10
66
Net unrealized losses on marketable securities
(4
(1
Net unrealized losses on cash flow hedges
(7
(8
Total other comprehensive (loss) income, net
(62
131
(503
561
Comprehensive income
2,257
5,152
3,025
10,275
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS (DEFICIT) EQUITY
For the Three and Nine Months Ended February 28, 2022 and 2021
(Unaudited)
Three Months Ended
February 28,
Nine Months Ended
February 28,
(in millions, except per share data)
2022
2021
2022
2021
Common stock and additional paid in capital
Balance, beginning of period
25,591
26,298
26,533
26,486
Common stock issued
52
143
357
915
Stock-based compensation
674
479
1,900
1,395
Repurchases of common stock
(65
(567
(1,648
(1,922
Other, net
(123
(92
(1,013
(613
Balance, end of period
26,129
26,261
26,129
26,261
Accumulated deficit
Balance, beginning of period
(34,076
(17,095
(20,120
(12,696
Repurchases of common stock
(535
(3,433
(13,952
(11,078
Cash dividends declared
(855
(699
(2,603
(2,146
Net income
2,319
5,021
3,528
9,714
Balance, end of period
(33,147
(16,206
(33,147
(16,206
Other stockholders (deficit) equity, net
Balance, beginning of period
(1,173
(587
(461
(1,073
Other comprehensive (loss) income, net
(62
131
(503
561
Other, net
42
38
(229
94
Balance, end of period
(1,193
(418
(1,193
(418
Total stockholders (deficit) equity
(8,211
9,637
(8,211
9,637
Cash dividends declared per common share
0.32
0.24
0.96
0.72
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended February 28, 2022 and 2021
(Unaudited)
Nine Months Ended
February 28,
(in millions)
2022
2021
Cash flows from operating activities:
Net income
3,528
9,714
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
1,409
1,127
Amortization of intangible assets
882
1,037
Deferred income taxes
(983
(2,475
Stock-based compensation
1,900
1,395
Other, net
82
227
Changes in operating assets and liabilities, net of effects from acquisitions:
Decrease in trade receivables, net
652
1,089
Decrease in prepaid expenses and other assets
71
609
Decrease in accounts payable and other liabilities
(683
(247
Decrease in income taxes payable
(661
(1,181
Decrease in deferred revenues
(643
(250
Net cash provided by operating activities
5,554
11,045
Cash flows from investing activities:
Purchases of marketable securities and other investments
(10,134
(26,775
Proceeds from sales and maturities of marketable securities and other investments
25,735
19,035
Acquisitions, net of cash acquired
(132
(29
Capital expenditures
(3,088
(1,418
Net cash provided by (used for) investing activities
12,381
(9,187
Cash flows from financing activities:
Payments for repurchases of common stock
(15,654
(12,958
Proceeds from issuances of common stock
357
915
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards
(1,011
(597
Payments of dividends to stockholders
(2,603
(2,146
Repayments of borrowings
(5,750
(2,631
Other, net
(439
241
Net cash used for financing activities
(25,100
(17,176
Effect of exchange rate changes on cash and cash equivalents
(251
400
Net decrease in cash and cash equivalents
(7,416
(14,918
Cash and cash equivalents at beginning of period
30,098
37,239
Cash and cash equivalents at end of period
22,682
22,321
Non-cash financing activities:
Change in unsettled repurchases of common stock
(54
42
See notes to condensed consolidated financial statements.
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2022
(Unaudited)
1.
BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER
Basis of Presentation
We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021.
We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for our fiscal year ending May 31, 2022.
The comparability of our condensed consolidated financial statements as of and for the nine months ended February 28, 2022 was impacted by $4.7 billion of certain litigation related charges that are more fully described in Note 11 below. The comparability of our condensed consolidated financial statements for the three and nine months ended February 28, 2021 was impacted by a $2.3 billion net income tax benefit related to the partial realignment of our legal entity structure that resulted in the intra-group transfer of certain intellectual property rights (refer to Notes 1 and 14 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended May 31, 2021 for additional information).
During the first nine months of fiscal 2022, we adopted Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes and ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, neither of which had a material impact to our condensed consolidated financial statements as of and for the nine months ended February 28, 2022. There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the nine months ended February 28, 2022.
Cash, Cash Equivalents and Restricted Cash
Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of February 28, 2022 and May 31, 2021 and our condensed consolidated statements of cash flows for the nine months ended February 28, 2022 and 2021 was nominal.
Remaining Performance Obligations from Contracts with Customers
Trade receivables, net of allowance for doubtful accounts, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of February 28, 2022 and May 31, 2021. The revenues recognized during the nine months ended February 28, 2022 and 2021, respectively, that were included in the opening deferred revenues balances as of May 31, 2021 and 2020, respectively, were approximately $8.1 billion and $7.4 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and nine months ended February 28, 2022 and 2021, respectively.
Remaining performance obligations, as defined in Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021, were $38.5 billion as of February 28,
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
February 28, 2022
(Unaudited)
2022, approximately 59% of which we expect to recognize as revenues over the next twelve months, 30% over the subsequent month 13 to month 36, and the remainder thereafter.
Sales of Financing Receivables
We offer certain of our customers the option to acquire certain of our cloud and license, hardware and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $352 million and $1.4 billion for the three and nine months ended February 28, 2022, respectively, and $338 million and $1.3 billion for the three and nine months ended February 28, 2021, respectively.
Non-Marketable Investments
Our non-marketable debt investments and equity securities and related instruments totaled $1.3 billion and $971 million as of February 28, 2022 and May 31, 2021, respectively, and are included either in other current assets or in other non-current assets in the accompanying consolidated balance sheets and are subject to periodic impairment reviews. Certain of these instruments are adjusted for observable price changes from orderly transactions. The substantial majority of the non-marketable debt investments and equity securities and related instruments held as of these dates were with a related party entity for which we follow the equity method of accounting. We are also a counterparty to certain options to acquire additional equity interests in that entity at various times through December 2023 and we could obtain control of that entity should such options be exercised.
Acquisition Related and Other Expenses
Acquisition related and other expenses consist of personnel related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net. For the nine months ended February 28, 2022, acquisition related and other expenses included certain litigation related charges that we generally do not expect to recur as further described in Note 11 below.
Three Months Ended
February 28,
Nine Months Ended
February 28,
(in millions)
2022
2021
2022
2021
Transitional and other employee related costs
Business combination adjustments, net
Other, net
13
10
4,693
100
Total acquisition related and other expenses
20
13
4,707
107
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
February 28, 2022
(Unaudited)
Non-Operating Expenses, net
Non-operating expenses, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan) and net other income and expenses, including net realized gains and losses related to all of our investments, net unrealized gains and losses related to the small portion of our investment portfolio related to our deferred compensation plan, net unrealized gains and losses related to equity securities, losses attributable to equity method investments, and non-service net periodic pension income and losses.
Three Months Ended
February 28,
Nine Months Ended
February 28,
(in millions)
2022
2021
2022
2021
Interest income
16
23
56
80
Foreign currency losses, net
(29
(18
(109
(84
Noncontrolling interests in income
(42
(46
(131
(127
Other, net
(260
24
(164
101
Total non-operating expenses, net
(315
(17
(348
(30
Recent Accounting Pronouncements
Financial Instruments: In March 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting and also issued subsequent amendments to the initial guidance (collectively, Topic 848). Topic 848 provides optional guidance for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. We will adopt Topic 848 when our relevant contracts are modified upon transition to alternative reference rates and expect this to occur through December 31, 2022. We do not expect our adoption of Topic 848 to have a material impact on our consolidated financial statements.
2.
ACQUISITIONS
Proposed Acquisition of Cerner Corporation
On December 20, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement) with Cerner Corporation (Cerner), a provider of digital information systems used within hospitals and health systems that are designed to enable medical professionals to deliver better healthcare to individual patients and communities.
On January 19, 2022, pursuant to the Merger Agreement, we commenced a tender offer to purchase all of the issued and outstanding shares of common stock of Cerner at a purchase price of $95.00 per share, net to the seller in cash, without interest thereon, based upon the terms and subject to the conditions set forth in the Offer to Purchase (Offer) dated January 19, 2022, and the related Letter of Transmittal. The tender offer period is scheduled to expire on March 16, 2022 however, the parties anticipate extending the tender offer period to allow additional time for the satisfaction of the remaining conditions to the tender offer. The consummation of the Offer is subject to the valid tender of a majority of the aggregate number of issued and outstanding Cerner shares. On February 23, 2022, the waiting period expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, but the consummation of the Offer remains conditioned on: (i) receipt of certain regulatory approvals and, if applicable, approval under certain other foreign antitrust laws and (ii) other customary conditions. After the consummation of the Offer and the satisfaction of certain conditions, a wholly-owned subsidiary of Oracle will merge with and into Cerner. In addition, the unvested equity awards to acquire Cerner common stock that were outstanding immediately prior to the consummation of the merger will generally be assumed by Oracle and
10
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
February 28, 2022
(Unaudited)
converted into equity awards denominated in shares of Oracle common stock based on formulas contained in the Merger Agreement. Vested equity awards outstanding immediately prior to the consummation of the merger generally will be cancelled in exchange for the right to receive an amount in cash based on a formula contained in the Merger Agreement. The preliminary estimated total purchase price for Cerner is approximately $28.5 billion.
Other Fiscal 2022 and 2021 Acquisitions
During the first nine months of fiscal 2022 and full year fiscal 2021, we acquired certain other companies and purchased certain technology and development assets primarily to expand our products and services offerings. These acquisitions were not significant individually or in the aggregate to our condensed consolidated financial statements.
3.
FAIR VALUE MEASUREMENTS
We perform fair value measurements in accordance with FASB Accounting Standards Codification (ASC) 820, Fair Value Measurement. ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions and risk of nonperformance.
ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset s or a liability s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
Level 1: quoted prices in active markets for identical assets or liabilities
Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities or
Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.
11
Table of Contents
ORACLE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
February 28, 2022
(Unaudited)
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1 and Level 2 inputs are defined above):
February 28, 2022
May 31, 2021
Fair Value Measurements
Using Input Types
Fair Value Measurements
Using Input Types
(in millions)
Level 1
Level 2
Total
Level 1
Level 2
Total
Assets:
Money market funds
12,877
12,877
12,263
12,263
Corporate debt securities and other
275
440
715
1,250
8,220
9,470
Commercial paper debt securities
11,712
11,712
Derivative financial instruments
73
73
Total assets
13,152
440
13,592
13,513
20,005
33,518
Liabilities:
Derivative financial instruments
33
33
We classify our marketable debt securities as available-for-sale securities at the time of purchase and reevaluate such classification as of each balance sheet date. Our marketable securities investments consist of money market funds, Tier 1 commercial paper debt securities, corporate debt securities and certain other securities. Marketable securities as presented per our condensed consolidated balance sheets included debt securities with original maturities at the time of purchase greater than three months and the remainder of the debt securities were included in cash and cash equivalents. As of February 28, 2022 and May 31, 2021, substantially all of our marketable debt securities investments mature within one year. Our valuation techniques used to measure the fair values of our instruments that were classified as Level 1 in the table above were derived from quoted market prices and active markets for these instruments that exist. Our valuation techniques used to measure the fair values of Level 2 instruments listed in the table above were derived from the following: non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques, with all significant inputs derived from or corroborated by observable market data including reference rate yield curves, among others.
Based on the trading prices of the $78.4 billion and $84.2 billion of senior notes and the related fair value hedges that we had outstanding as of February 28, 2022 and May 31, 2021, respectively, the estimated fair values of the senior notes and the related fair value hedges using Level 2 inputs at February 28, 2022 and May 31, 2021 were $76.6 billion and $89.6 billion, respectively.